Genezen Partners with Humane Genomics to Enhance Pediatric Liver Cancer Treatment through Innovative Oncolytic Virus Therapy Genezen and Humane Genomics form a partnership to develop HGI627, a pioneering oncolytic viral therapy for pediatric liver cancer, with a focus on patient safety and efficacy.

Genezen Partners with Humane Genomics to Enhance Pediatric Liver Cancer Treatment through Innovative Oncolytic Virus Therapy #United_States #Indianapolis #Genezen #Humane_Genomics #Oncolytic_Therapy